|Related Categories||AIDS and Viral Research Reagents, Bioactive Small Molecules, Cell Biology, Cell Signaling and Neuroscience, D-DIF,|
Nucleoside analog which inhibits HIV replication in vitro.
Lin, T.S., et al. Biochem. Pharmacol. 17, 2713, (1987)
Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. Baba, M., et al. Biochem. Biophys. Res. Commun. 142, 128, (1987)
Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand. Kyaw NL, Thanachartwet V, Kiertiburanakul S, et al. Southeast Asian J. Trop. Med. Public Health 44(2), 232-43, (2013)
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. Tang MW, Rhee SY, Bertagnolio S, et al. J. Infect. Dis. 207 Suppl 2, S70-7, (2013)
Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients. Feleke Y, Fekade D, and Mezegebu Y Ethiop. Med. J. 50(3), 221-30, (2012)
Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus. Shiau S, Arpadi S, Strehlau R, et al. J. Pediatr. 162(6), 1138-45, 1145.e1-2, (2013)
Phasing out the use of stavudine in Singapore: how are we doing in compliance to World Health Organization (WHO) recommendations? Win MK, Leo YS, and Chua A Ann. Acad. Med. Singapore 41(12), 615-6, (2012)
Corrections for "Thermodynamic modeling of activity coefficient and prediction of solubility. Parts 1 and 2," Journal of Pharmaceutical Sciences 95(4) 2006, pp 790-809. Mirmehrabi M and Rohani S J. Pharm. Sci. 102(3), 786, (2013)
A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine. Phanuphak N, Ananworanich J, Teeratakulpisarn N, et al. Antivir. Ther. (Lond.) 17(8), 1521-31, (2012)
Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy. Arpadi S, Shiau S, Strehlau R, et al. Arch. Dis. Child. 98(4), 258-64, (2013)
The artifactual nature of stavudine binding to human serum albumin. A fluorescence quenching and isothermal titration calorimetry study. Neamtu S, Mic M, Bogdan M, et al. J. Pharm. Biomed. Anal. 72, 134-8, (2013)
Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 subtype CRF01_AE. Praparattanapan J, Kotarathitithum W, Chaiwarith R, et al. Curr. HIV Res. 10(8), 647-52, (2012)
Association of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapy. Domingo P, Cabeza Mdel C, Torres F, et al. PLoS ONE 8(2), e57347, (2013)
Impact of recommendation updates in well-controlled patients on nonrecommended antiretroviral therapies: the Swiss HIV cohort study. Boillat-Blanco N, Darling KE, Taffe P, et al. J. Acquir. Immune Defic. Syndr. 62(2), 180-9, (2013)
In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs. Hukezalie KR, Thumati NR, Côté HC, et al. PLoS ONE 7(11), e47505, (2012)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Need larger quantities for your development, manufacturing or research applications?